125 related articles for article (PubMed ID: 8359568)
21. Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine.
Nightingale JM; Walker ER; Burnham WR; Farthing MJ; Lennard-Jones JE
Aliment Pharmacol Ther; 1989 Aug; 3(4):367-73. PubMed ID: 2518850
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping.
Arts J; Caenepeel P; Bisschops R; Dewulf D; Holvoet L; Piessevaux H; Bourgeois S; Sifrim D; Janssens J; Tack J
Clin Gastroenterol Hepatol; 2009 Apr; 7(4):432-7. PubMed ID: 19264574
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic value of octreotide for patients with severe dumping syndrome--a review of randomised controlled trials.
Li-Ling J; Irving M
Postgrad Med J; 2001 Jul; 77(909):441-2. PubMed ID: 11423592
[No Abstract] [Full Text] [Related]
24. Vasoactive substances in early dumping syndrome: effects of dumping provocation with and without octreotide.
Vecht J; Gielkens HA; Frölich M; Lamers CB; Masclee AA
Eur J Clin Invest; 1997 Aug; 27(8):680-4. PubMed ID: 9279532
[TBL] [Abstract][Full Text] [Related]
25. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
[TBL] [Abstract][Full Text] [Related]
26. Long-term results of octreotide-therapy in severe dumping syndrome.
Vecht J; Lamers CB; Masclee AA
Clin Endocrinol (Oxf); 1999 Nov; 51(5):619-24. PubMed ID: 10594523
[TBL] [Abstract][Full Text] [Related]
27. Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995.
Hopman WP; Wolberink RG; Lamers CB; Van Tongeren JH
Ann Surg; 1988 Feb; 207(2):155-9. PubMed ID: 2893592
[TBL] [Abstract][Full Text] [Related]
28. The effects of octreotide, soy polysaccharide, codeine and loperamide on nutrient, fluid and electrolyte absorption in the short-bowel syndrome.
Rodrigues CA; Lennard-Jones JE; Thompson DG; Farthing MJ
Aliment Pharmacol Ther; 1989 Apr; 3(2):159-69. PubMed ID: 2491467
[TBL] [Abstract][Full Text] [Related]
29. Pectin in the dumping syndrome: reduction of symptoms and plasma volume changes.
Leeds AR; Ralphs DN; Ebied F; Metz G; Dilawari JB
Lancet; 1981 May; 1(8229):1075-8. PubMed ID: 6112448
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome.
Penning C; Vecht J; Masclee AA
Aliment Pharmacol Ther; 2005 Nov; 22(10):963-9. PubMed ID: 16268971
[TBL] [Abstract][Full Text] [Related]
31. Short bowel syndrome and somatostatin 201-995.
Rambaud JC
Gut; 1990 Jan; 31(1):124. PubMed ID: 2318426
[No Abstract] [Full Text] [Related]
32. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
Folwaczny C; Läritz M; Meurer M; Endres SP; König A; Schindlbeck N
Z Gastroenterol; 1997 Oct; 35(10):905-12. PubMed ID: 9432812
[TBL] [Abstract][Full Text] [Related]
33. [Postgastrectomy dumping treated with octreotide (Sandostatin)].
Møller TD; Carlsen CU
Ugeskr Laeger; 1993 Jun; 155(23):1805-6. PubMed ID: 8317033
[TBL] [Abstract][Full Text] [Related]
34. Somatostatin and the dumping syndrome.
Long RG; Adrian TE; Bloom SR
Br Med J (Clin Res Ed); 1985 Mar; 290(6472):886-8. PubMed ID: 2858244
[TBL] [Abstract][Full Text] [Related]
35. [Could delayed action flanreotide be used as substitute for octreotide in the treatment of dumping syndrome?].
Bouché O; Salmon-Ettersperger L; Frémond L; Thiéfin G; Zeitoun P
Gastroenterol Clin Biol; 1997; 21(1):84-5. PubMed ID: 9091398
[No Abstract] [Full Text] [Related]
36. Incretin effects, gastric emptying and insulin responses to low oral glucose loads in patients after gastric bypass and lean and obese controls.
Wölnerhanssen BK; Meyer-Gerspach AC; Peters T; Beglinger C; Peterli R
Surg Obes Relat Dis; 2016 Aug; 12(7):1320-1327. PubMed ID: 27012873
[TBL] [Abstract][Full Text] [Related]
37. Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome.
O'Keefe SJ; Peterson ME; Fleming CR
JPEN J Parenter Enteral Nutr; 1994; 18(1):26-34. PubMed ID: 8164299
[TBL] [Abstract][Full Text] [Related]
38. [The role of long-acting release (LAR) depot octreotide as adjuvant management of short bowel disease].
Gómez-Herrera E; Farías-Llamas OA; Gutiérrez-de la Rosa JL; Hermosillo-Sandoval JM
Cir Cir; 2004; 72(5):379-86. PubMed ID: 15550227
[TBL] [Abstract][Full Text] [Related]
39. Long-acting analogue of somatostatin--SMS 201-995--is highly effective in the prevention of clinical symptoms related to the dumping syndrome.
Tulassay Z; Tulassay T; Gupta R; Cierny G
Ann Surg; 1989 Aug; 210(2):250-2. PubMed ID: 2757427
[No Abstract] [Full Text] [Related]
40. Long-term symptomatic relief of postprandial hypoglycaemia following gastric surgery with a somatostatin analogue.
D'Cruz DP; Reynard J; Tatman AJ; Kopelman PG
Postgrad Med J; 1989 Feb; 65(760):116-7. PubMed ID: 2780462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
